px563l
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02655549)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Bacillus anthracisImmunity, active
Bacillus anthracis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- px563l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02655549 | Phase 1 | Dec 1, 2015 | Department of Health and Human Services, IQVIA, Pfenex, Inc |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2015 |
| IQVIA | For profit | 1 | 0 | 1 | 2015 |
| Pfenex, Inc | For profit | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1